Biography for Ron Shinkman
It's rare when you can mutter the words "novelist," "Jeopardy contestant" and "FierceHealthFinance" in the same breath. But Ron Shinkman, editor of FierceHealthFinance, makes it all possible. Besides writing a novel that one Amazon.com reviewer deemed a "wry thriller," Ron once won $16,000 as a Jeopardy contestant!
No doubt Ron amassed his plot ideas--not to mention mounds of miscellaneous trivia--during nearly two decades as a journalist. You may remember Ron from his years as the Los Angeles Bureau Chief of Modern Healthcare, where he focused on corporate governance issues. Or maybe you recognize his byline from the Los Angeles Business Journal, where he covered the healthcare and insurance beats. He has also written for HealthLeaders Media, Trustee magazine, and Payer & Providers. He can be reached at firstname.lastname@example.org. Follow him @FierceHealth on Twitter and find him on LinkedIn.
Articles by Ron Shinkman
Where have all the community benefits gone? That's a question asked by the Berkeley, CA-based Greenlining Institute, which recently examined how hospitals in San Francisco were expending their community benefits. Greenlining could not find much of an answer.
Medicare may penalize many hospitals for patient readmissions due to circumstances that are beyond their control, according to Forbes contributor Peter Ubel.
The shift toward consumer-driven healthcare could wind up cutting the number of patients receiving care via the hospital inpatient setting by as much as 40 percent over the long term, according to a new report by the Oliver Wyman consulting firm.
The Centers for Medicare & Medicaid Services has issued an update on its settlement process with providers regarding disputed short-term hospital claims
The average hospital liability claim is approaching $500,000, according to new data from the American Society for Healthcare Risk Management.
Challenged by insurers ratcheting down their payments, hospitals and medical groups are creating more fees and charges for patients to pay as part of the care they receive, The New York Times reported.
The Health Resources and Services Administration had decided that orphan drugs--often pricey medications used to treat rare diseases--should be provided in some instances to hospitals that participate in the 340B program at its permitted discount, according to AHA News Now.
As hospitals scramble to properly prepare for any further outbreaks of the Ebola virus in the United States, they are bumping up against the inevitable barrier: cost. Hospitals are finding that merely preparing for the narrow possibility of treating an Ebola patient can cost them hundreds of thousands of dollars.
Public health initiatives are being more widely financed with private investors, Kaiser Health News has reported. "Pay for success" or "social impact bonds" originated in the United Kingdom, although they are getting some purchase in the United States.